Cadrenal Therapeutics, Inc. (CVKD)
CIK 1937993 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cadrenal Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 3, 2026 | S-8 | 0001213900-26-097282 |
| Aug 31, 2026 | 8-K | 0001213900-26-095394 |
| Aug 13, 2026 | 8-K | 0001213900-26-089147 |
| Aug 13, 2026 | 10-Q | 0001213900-26-089153 |
| Aug 7, 2026 | SCHEDULE 13G | 0001193125-26-339234 |
| Aug 3, 2026 | DEF 14A | 0001213900-26-084710 |
| Aug 3, 2026 | ARS | 0001213900-26-084713 |
| Aug 3, 2026 | DEFA14A | 0001213900-26-084716 |
| Jul 23, 2026 | PRE 14A | 0001213900-26-081012 |
| Jul 21, 2026 | 8-K | 0001213900-26-079824 |
| Jul 20, 2026 | 424B3 | 0001213900-26-079648 |
| Jul 20, 2026 | EFFECT | 9999999995-26-002367 |
| Jul 17, 2026 | 8-K | 0001213900-26-079176 |
| Jul 15, 2026 | D | 0001213900-26-078373 |
| Jul 13, 2026 | S-3 | 0001213900-26-077647 |
| Jul 10, 2026 | 8-K | 0001213900-26-077134 |
| Jul 1, 2026 | 8-K | 0001213900-26-074421 |
| Jul 1, 2026 | 4 | 0001213900-26-074557 |
| Jun 29, 2026 | 8-K | 0001213900-26-073213 |
| Jun 26, 2026 | 4 | 0001213900-26-072789 |
| Jun 24, 2026 | 4 | 0001213900-26-071578 |
| Jun 18, 2026 | 8-K | 0001213900-26-069902 |
| Jun 18, 2026 | 4 | 0001213900-26-070248 |
| Jun 15, 2026 | 4 | 0001213900-26-068981 |
| Jun 15, 2026 | 144 | 0001628280-26-043385 |